Neurokinin 1 receptor antagonists exhibit peripheral effects in prurigo nodularis including reduced ERK1/2 activation.
K AgelopoulosF RülanderJ DangelmaierT LottsN OsadaD MetzeT A LugerK LoserPamela GuglielminiPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)
Our data confirm that NK1R antagonists such as aprepitant exhibit effects in the skin. Epidermal receptor expression, epidermal inflammatory ILs, ERK1/2 MAPK signalling and cutaneous inflammatory infiltrate were targets of NK1R antagonism. This may explain partly the antipruritic effect of NK1R antagonists next to its role in the central nervous system.